<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>CLINICAL RESEARCH &amp; DIAGNOSTICS Patent News news from GEN</title><description>News about patent applications and approvals.</description>
<lastBuildDate>Friday, March 12, 2010</lastBuildDate><link>http://www.genengnews.com/news/newslist.aspx?taxid=27</link>
<item>
<title>NMT Medical Announces Completion of Eight-Member Scientific Advisory Board</title>
<description></description>
<pubDate>Thursday, March 11, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=77510810</link>
</item>
<item>
<title>Seattle Genetics Expands Antibody-Drug Conjugate Patent Portfolio</title>
<description></description>
<pubDate>Thursday, March 11, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=77506382</link>
</item>
<item>
<title>Precision BioSciences Announces that the European Patent Office Issues Written Decision Confirming Cellectis’ Loss of Patent Protection for Single-Chain Meganucleases in Europe</title>
<description></description>
<pubDate>Thursday, March 11, 2010</pubDate>
<link>http://www.genengnews.com/news/bnitem.aspx?name=77496528</link>
</item>
</channel>
</rss>
